Faced With Declining Test Orders, Foundation Medicine Vows to Push Doctor Education, Reimbursement | GenomeWeb

NEW YORK (GenomeWeb) – Foundation Medicine plans to counter a decrease in its clinical testing business with initiatives to educate doctors, help them utilize test results for treatment, and by pushing for reimbursement, the firm's management said this week.

Earlier this week, the company reported a 10 percent sequential drop in the number of clinical tests it conducted in the third quarter and lowered the number of tests expected for 2015, sending its stock down.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.